Serological Approaches

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F17%3A00095970" target="_blank" >RIV/00216224:14110/17:00095970 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1007/978-1-4939-6515-1_11" target="_blank" >http://dx.doi.org/10.1007/978-1-4939-6515-1_11</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/978-1-4939-6515-1_11" target="_blank" >10.1007/978-1-4939-6515-1_11</a>

Result language
angličtina
Original language name
Serological Approaches
Original language description
The diagnosis of invasive fungal diseases (IFD) based on clinical, radiological, and conventional microbiological findings is not reliable and is often delayed. Non-culture-based methods with higher sensitivity and specificity may reduce diagnostic time and result in decreased IFD morbidity and mortality. These methods are now increasingly used to manage patients at risk of IFD. Among available biomarkers, fungal antigens have been investigated as an aid to early diagnosis and are predominantly used as screening tests to prompt antifungal treatment mainly in patients with hematological malignancies. The revised version of the European Organization for Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) consensus definitions includes some of these biological markers (galactomannan, 1,3-beta-d-glucan, cryptococcus antigen).
Czech name
—
Czech description
—

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Book/collection name
Human Fungal Pathogen Identification : Methods and Protocols
ISBN
9781493965137
Number of pages of the result
13
Pages from-to
209-221
Number of pages of the book
453
Publisher name
Springer
Place of publication
New York
UT code for WoS chapter
—

Similar results(10)